Kao Chia-Cheng, Chen Ke-Cheng, Chiang Xu-Heng, Chuang Jen-Hao, Lu Chao-Wen, Hsiao Wei-Ling, Lin Tzu-Hsin, Liao Hsien-Chi
Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan.
Division of Thoracic Surgery, Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan.
World J Emerg Surg. 2025 May 19;20(1):40. doi: 10.1186/s13017-025-00620-8.
Rib fractures are common chest wall injuries with conservative treatment and surgical stabilization of rib fractures (SSRF) as treatment options. We retrospectively compared the efficacy and long-term prognosis of conservative treatment and SSRF as treatment options for rib fractures.
This retrospective study was conducted at a single trauma center in Taiwan. The study population comprised patients with rib fractures who underwent conservative treatment or SSRF at the National Taiwan University Hospital between 2017 and 2022. We analyzed the outcomes between the operative and non-operative groups, including the length of intensive care unit and hospital stays, pain scales at admission and follow-up, and post-operative complication rates.
Of the 217 patients with rib fractures in this study, 103 received SSRF, and 114 received conservative treatment. Patients in the operative group had worse consciousness statuses and higher injury severity scores than those in the non-operative group. In addition, patients in the operative group had more preoperative chest complications than those in the non-operative group. Regarding outcomes and long-term prognoses, patients in the operative group had longer intensive care unit and hospital stays than those in the non-operative group; however, patients in the operative group had better recovery quality than those in the non-operative group.
Our study showed that, in patients who meet the surgical indications, SSRF is an effective and safe way to relieve acute pain after thoracic injury and achieve better recovery and quality of life after surgical intervention.
肋骨骨折是常见的胸壁损伤,治疗选择包括保守治疗和肋骨骨折手术固定(SSRF)。我们回顾性比较了保守治疗和SSRF作为肋骨骨折治疗方案的疗效和长期预后。
这项回顾性研究在台湾的一个单一创伤中心进行。研究人群包括2017年至2022年期间在台湾大学医院接受保守治疗或SSRF的肋骨骨折患者。我们分析了手术组和非手术组的结果,包括重症监护病房住院时间和住院时间、入院时和随访时的疼痛评分以及术后并发症发生率。
本研究中的217例肋骨骨折患者中,103例接受了SSRF,114例接受了保守治疗。手术组患者的意识状态比非手术组差,损伤严重程度评分更高。此外,手术组患者术前胸部并发症比非手术组多。关于结果和长期预后,手术组患者的重症监护病房住院时间和住院时间比非手术组长;然而,手术组患者的恢复质量比非手术组好。
我们的研究表明,在符合手术指征的患者中,SSRF是缓解胸部损伤后急性疼痛并在手术干预后实现更好恢复和生活质量的有效且安全的方法。